Of interest, our findings through DNA methylation level analysis by using UALCAN database also support the consistent trend, which show LSM2, LSM4, LSM10 were upregulated in primary breast tumors, while LSM6 methylation levels were downregulated. The gene discussed is LSM6; the disease is breast neoplasm.